Glenmark Pharmaceuticals Falls 3.10%: 3 Key Factors Driving the Weekly Move

Monday, 5 January: Bullish Technical Momentum Emerges

Glenmark Pharmaceuticals began the week with a notable shift in technical momentum, upgrading from mildly bullish to bullish. The stock closed at Rs.2,038.70, down 1.56% from the previous close, but technical indicators such as MACD and Bollinger Bands signalled strengthening upward momentum. The price remained comfortably above key moving averages, suggesting sustained near-term strength despite the day's decline.

The stock’s intraday range between Rs.2,013.95 and Rs.2,072.00, closing near the high, demonstrated resilience. Relative Strength Index (RSI) readings remained neutral, indicating room for further upside without overbought conditions. The weekly On-Balance Volume (OBV) was mildly bullish, supporting the price gains. Glenmark’s Mojo Score was upgraded to 91.0, categorising it as a Strong Buy, reflecting enhanced investor confidence.

Tuesday, 6 January: Mixed Technical Signals Amid Modest Price Gain

On 6 January, Glenmark’s stock price rebounded to Rs.2,074.50, gaining 1.76%, outperforming the Sensex which declined 0.19%. However, the technical momentum softened from bullish to mildly bullish, reflecting a more cautious market stance. The MACD remained positive, but the Know Sure Thing (KST) indicator showed mild bearishness, signalling potential short-term consolidation.

Volume was subdued at 5,432 shares, and On-Balance Volume (OBV) showed no clear trend, indicating mixed investor participation. Bollinger Bands suggested moderate upward pressure, while RSI remained neutral. The stock traded within a relatively tight range, with intraday highs of Rs.2,091.80 and lows of Rs.2,031.45, maintaining a position well above its 52-week low of Rs.1,274.70.

Wednesday, 7 January: Call Option Activity Surges Amid Bullish Momentum

Glenmark saw a significant surge in call option trading on 7 January, with 9,730 contracts exchanged at the Rs.2,100 strike price expiring 27 January 2026. The underlying stock closed at Rs.2,113.10, up 1.86%, outperforming the Pharmaceuticals & Biotechnology sector by 2.16% and the Sensex by 0.03%. Intraday, the stock touched a high of Rs.2,147.50, a 3.51% gain from the previous close.

This call option activity, generating a turnover of approximately Rs.2,330.46 lakhs, indicates strong bullish sentiment among investors anticipating further gains. The stock traded above all key moving averages, reinforcing the technical uptrend. However, delivery volumes declined sharply, suggesting that the rally may be driven more by speculative option positioning than sustained cash market buying.

Thursday, 8 January: Sharp Decline Amid Broader Market Weakness

The stock reversed course on 8 January, closing at Rs.2,078.30, down 1.65%, while the Sensex fell 1.41%. This decline followed the previous day’s bullish momentum and coincided with a broader market sell-off. Volume increased to 16,609 shares, reflecting heightened trading activity. Technical indicators suggested increased volatility, with Bollinger Bands widening and RSI remaining neutral.

The price drop may reflect profit-taking after the surge in call option activity and the stock’s recent gains. Despite the decline, Glenmark remained above key moving averages, indicating that the longer-term uptrend was intact but facing short-term pressure.

Friday, 9 January: Week Ends Lower on Heavy Selling Pressure

Glenmark closed the week at Rs.2,006.90, down 3.44% on the day and marking a 3.10% loss for the week. The Sensex also declined 0.89%, but Glenmark’s weekly underperformance was more pronounced. The stock’s volume was 10,669 shares, reflecting moderate investor activity. The decline capped a volatile week characterised by shifting technical momentum and speculative option positioning.

Despite the weekly loss, Glenmark outperformed the Sensex on three of the five trading days, highlighting intermittent strength. The stock’s technical profile remains mixed, with bullish MACD and moving averages offset by bearish KST and declining delivery volumes. Investors should monitor these signals closely for indications of trend continuation or reversal.

Daily Price Performance vs Sensex

Key Takeaways

Positive Signals: Glenmark Pharmaceuticals demonstrated technical strength early in the week with a bullish momentum upgrade and strong MACD and moving average alignment. The surge in call option activity on 7 January reflects robust investor optimism and anticipation of further gains. The stock outperformed the Sensex on three trading days, highlighting intermittent resilience.

Cautionary Signals: Despite early strength, the stock closed the week down 3.10%, underperforming the benchmark. Mixed technical indicators such as the mildly bearish KST and declining delivery volumes suggest potential short-term consolidation or profit-taking. The sharp declines on 8 and 9 January amid broader market weakness underline vulnerability to external market pressures.

Overall, Glenmark’s technical and fundamental profile remains strong but requires close monitoring of volume trends and momentum indicators to assess sustainability of the current phase.

Conclusion

The week for Glenmark Pharmaceuticals was characterised by a complex interplay of bullish momentum and cautious consolidation. Early technical upgrades and strong call option activity signalled investor confidence, yet the stock ended the week lower amid broader market declines and mixed volume signals. While Glenmark outperformed the Sensex on several days, the weekly loss of 3.10% highlights the challenges of sustaining momentum in a volatile environment.

Investors should weigh the positive technical signals against cautionary volume and momentum indicators. The stock’s strong Mojo Score and sector positioning provide a solid foundation, but vigilance is warranted as the market navigates near-term uncertainties. Monitoring option expiry dynamics and delivery volumes will be key to understanding the stock’s next directional move.

Unlock special upgrade rates for a limited period. Start Saving Now →